Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM1 | Q13255 | 5/20 | 0.51 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.50 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | AVPR1A | P37288 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23875675 | 1.00 | GRM1 (0.51) | GRM1PLD1GPR119PDE10AAVPR1A | |
| SCHEMBL13572999 | 0.90 | GRM1 (0.52) | GRM1PLD1KDM4EALDH1A1MAPT | |
| SCHEMBL19844773 | 0.90 | GRM1 (0.52) | GRM1PLD1KDM4EALDH1A1MAPT | |
| SCHEMBL19844779 | 0.90 | GRM1 (0.52) | GRM1PLD1KDM4EALDH1A1MAPT | |
| SCHEMBL29774590 | 0.89 | PLD1 (0.58) | PLD1GPR119AVPR1AKDM4EALDH1A1 | |
| SCHEMBL359401 | 0.89 | PLD1 (0.58) | PLD1GPR119AVPR1AKDM4EALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL8126869 | 0.88 | PLD1 (0.56) | PLD1GPR119AVPR1AKDM4EALDH1A1 | |
| SCHEMBL23875353 | 0.85 | PLD1 (0.52) | GRM1PLD1KDM4EALDH1A1MAPT | |
| SCHEMBL29991351 | 0.82 | GRIN2B (0.49) | GRM1PLD1KDM4EALDH1A1MAPT | |
| SCHEMBL24548016 | 0.82 | GRM1 (0.48) | GRM1PLD1GPR119AVPR1AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3856735-B1 | FUSED BICYCLIC HETEROCYCLES AS THERAPEUTIC AGENTS | UNIV NEW YORK (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2021194878-A1 | SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| EP-3193604-B1 | SUBSTITUTED N-(PYRROLIDIN-3-YL)ISOXAZOLE-3-CARBOXAMIDE COMPOUNDS | EPIZYME INC (US) | 2021-06-16 | — | — | EP | disclosed |
| EP-3689868-A1 | TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas Operations, Inc. (US) | 2020-08-05 | — | — | EP | disclosed |
| WO-2016044792-A1 | INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL | HYDRA BIOSCIENCES, INC. (US) | 2016-03-24 | — | — | WO | disclosed |
| EP-2203459-B1 | SPIROCYCLIC AMINOQUINOLONES AS GSK-3 INHIBITORS | KYORIN SEIYAKU KK (JP) | 2016-03-16 | — | — | EP | disclosed |
| US-9199946-B2 | Pyrimidinone carboxamide inhibitors of endothelial lipase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-20150065505-A1 | PYRIMIDINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-03-05 | — | — | US | disclosed |
| US-8901112-B2 | Spirocyclic aminoquinolones as GSK-3 inhibitors | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8901112-B2 | Spirocyclic aminoquinolones as GSK-3 inhibitors | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-5084509-A | Peptides or proteins bound to aminoalkyl polydimethylacrylamide for immunology | BAYLOR COLLEGE OF MEDICINE (US) | 1992-01-28 | — | — | US | disclosed |
| US-5028675-A | Polyamide resin and method for preparation of reagents for immunodiagn ostic use | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1991-07-02 | — | — | US | disclosed |
| WO-1990015627-A1 | METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF SITE-DIRECTED IMMUNOLOGIC REAGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-12-27 | — | — | WO | disclosed |
| US-4973638-A | DIMETHYLACRYLAMIDE, N-ACRYLYL DIAMINOALKANE, CROSSLINKER, AND EMULSIFIER | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCHE (US) | 1990-11-27 | — | — | US | disclosed |
| EP-0276279-A4 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC. | SOUTHWEST FOUND BIOMED RES (US) | 1990-01-08 | — | — | EP | disclosed |
| EP-0265501-A4 | POLYAMIDE RESIN AND METHOD FOR PREPARATION OF REAGENTS FOR IMMUNODIAGNOSTIC USE. | SOUTHWEST FOUND BIOMED RES (US) | 1988-11-09 | — | — | EP | disclosed |
| EP-0276279-A1 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1988-08-03 | — | — | EP | disclosed |
| EP-0265501-A1 | POLYAMIDE RESIN AND METHOD FOR PREPARATION OF REAGENTS FOR IMMUNODIAGNOSTIC USE | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1988-05-04 | — | — | EP | disclosed |
| WO-1988000471-A1 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1988-01-28 | — | — | WO | disclosed |
| WO-1987006594-A1 | POLYAMIDE RESIN AND METHOD FOR PREPARATION OF REAGENTS FOR IMMUNODIAGNOSTIC USE | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1987-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150065505-A1 | PYRIMIDINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE | LIPG, LPL, PNLIP | GRM1 2782/4885PLD1 152/4885GPR119 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.